Skip to content

Evidence

Impact of an integrated AI platform on prostate MRI interpretation: a multi-reader study

ECR: Poster Presentation
Everitt  et al. 2026

 

While prostate MRI can improve prostate cancer (PCa) detection and enable more accurate MRI-guided fusion-biopsy, these gains require radiologist expertise. Shortages of expert radiologists and inter-reader variability can lead to inconsistent diagnoses and suboptimal biopsy targeting. AI could improve radiologists’ interpretations. We evaluated an integrated AI web-based platform providing fully automated lesion segmentation and lesion-level risk classification, assessing effects on PCa detection, localisation and inter-reader consistency.

Disclaimers: DeepHealth Prostate is manufactured as Quantib Prostate by Quantib BV for DeepHealth Inc., DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc., DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc. and DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us